Guselkumab, an IL-23 inhibitor, is effective in reducing signs, symptoms, and structural damage in active PsA, as confirmed by the APEX study. The FDA approved guselkumab in 2020 based on DISCOVER ...
While the legacy of the MCU’s original Avengers is plain to see within the franchise, many of the heroes that formed the team are no longer active in its stories. Additionally, some of Phase 1’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results